Protoporphyrin IX
(Synonyms: 原卟啉IX) 目录号 : GC19403
Protoporphyrin IX是一种在血红素生物合成途径中的重要的卟啉类化合物,常被用于光动力疗法中。
Cas No.:553-12-8
Sample solution is provided at 25 µL, 10mM.
Protoporphyrin IX is an important porphyrin compound in the heme biosynthetic pathway and is commonly used in photodynamic therapy[1]. Protoporphyrin IX binds with iron ions to form ferrous protoporphyrin, which then combines with globin to generate hemoglobin, thereby maintaining oxygen transport and cellular respiration functions[2]. In photodynamic therapy, Protoporphyrin IX primarily serves as a photosensitizer, capable of absorbing specific wavelengths of light and generating reactive oxygen species[3]. In addition, the fluorescence imaging of Protoporphyrin IX (excitation wavelength 488nm, emission wavelength 620nm) can also be utilized to improve surgical outcomes[4].
In vitro, Protoporphyrin IX (10-30μM) treatment of SK-MEL-2 melanoma cells and human normal melanocytes (HNM) for 48 hours significantly promotes melanin synthesis, increases tyrosinase activity, and upregulates the expression levels of MITF, tyrosinase, TRP-1, and TRP-2, while also promoting dendrite formation and melanosome transport in melanocytes[5]. The novel conjugate CH−PPIX (0.005%, w/v) formed by Protoporphyrin IX and chitosan oligosaccharides (CH) exhibits 100% inhibitory efficiency against Penicillium digitatum under visible light irradiation. This conjugate exerts antifungal effects through the generation of singlet oxygen, leading to spore uptake and photoinduced membrane damage[6].
In vivo, Protoporphyrin IX (3.5mg/kg) was administered to mice via a single intraperitoneal injection or daily injections for 5 consecutive days. Two hours after a single dose, the accumulation of porphyrins in the mouse liver peaked. After five doses, Protoporphyrin IX accumulation induced oxidative stress, causing severe liver damage and impairing the antioxidant system[7]. Protoporphyrin IX-modified oxidized mesoporous carbon nanospheres (1mg/kg) were injected into APP/PS1 transgenic mice via the tail vein and activated by focused ultrasound. These nanospheres could effectively cross the blood-brain barrier (BBB), significantly inhibit Tau protein phosphorylation and β-amyloid (Aβ) aggregation, and improve cognitive function in mice[8].
References:
[1] Juzenas P, Juzeniene A, Stakland S, et al. Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice. Biochem Biophys Res Commun. 2002 Sep 27;297(3):468-72.
[2] Kiening M, Lange N. A Recap of Heme Metabolism towards Understanding Protoporphyrin IX Selectivity in Cancer Cells. Int J Mol Sci. 2022 Jul 19;23(14):7974.
[3] Hussain Z, Qi Q, Zhu J, Anderson KE, et al. Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics. Pharmacol Ther. 2023 Aug;248:108487.
[4] Valdes PA, Millesi M, Widhalm G, et al. 5-aminolevulinic acid induced protoporphyrin IX (ALA-PpIX) fluorescence guidance in meningioma surgery. J Neurooncol. 2019 Feb;141(3):555-565.
[5] Lv J, An X, Jiang S, Yang Y, et al. Protoporphyrin IX Stimulates Melanogenesis, Melanocyte Dendricity, and Melanosome Transport Through the cGMP/PKG Pathway. Front Pharmacol. 2020 Sep 11;11:569368.
[6] Dibona-Villanueva L, Fuentealba D. Protoporphyrin IX-Chitosan Oligosaccharide Conjugate with Potent Antifungal Photodynamic Activity. J Agric Food Chem. 2022 Aug 3;70(30):9276-9282.
[7] Afonso S, Vanore G, Batlle A. Protoporphyrin IX and oxidative stress. Free Radic Res. 1999 Sep;31(3):161-70.
[8] Xu M, Zhou H, Liu Y, Sun J, et al. Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and β-Amyloid Aggregation. ACS Appl Mater Interfaces. 2018 Oct 3;10(39):32965-32980.
Protoporphyrin IX是一种在血红素生物合成途径中的重要的卟啉类化合物,常被用于光动力疗法中 [1]。Protoporphyrin IX通过与铁离子结合形成亚铁原卟啉进而与珠蛋白结合生成血红蛋白。从而维持氧气运输和细胞呼吸功能[2]。Protoporphyrin IX在光动力疗法中主要作为光敏剂,能够吸收特定波长的光并产生活性氧,从而对病变组织或肿瘤细胞实现精准打击[3]。此外,还可利用Protoporphyrin IX的荧光成像(激发光波长为488nm,发射光波长为620nm)改善手术结果[4]。
在体外,Protoporphyrin IX(10-30μM)处理SK-MEL-2黑色素瘤细胞和人正常黑色素细胞(HNM)48小时,显著促进黑色素合成,增加酪氨酸酶活性及MITF、酪氨酸酶、TRP-1和TRP-2的表达水平,同时促进黑色素细胞树突形成和黑色素小体运输[5]。Protoporphyrin IX与壳寡糖(CH)形成的新型共轭物CH−PPIX(0.005%,w/v)在可见光照射下对青霉菌表现出100%的抑制效率。该共轭物通过单线态氧的生成导致孢子摄取和光诱导的膜损伤,从而发挥抗真菌作用[6]。
在体内,Protoporphyrin IX(3.5mg/kg)单剂量或每日一次连续5天腹腔注射给小鼠。单剂量后2小时,小鼠肝脏中卟啉积累达到峰值。5次剂量后,Protoporphyrin IX积累诱导氧化应激,导致肝脏损伤严重,同时损害抗氧化系统[7]。Protoporphyrin IX修饰的氧化介孔碳纳米球(1mg/kg)通过尾静脉注射于APP/PS1转基因小鼠模型中,通过聚焦超声(US)激发后,Protoporphyrin IX修饰的氧化介孔碳纳米球能够有效穿越血脑屏障(BBB),显著抑制Tau蛋白磷酸化和β-淀粉样蛋白(Aβ)聚集,提高小鼠的认知水平[8]。
Cell experiment [1]: | |
Cell lines | SK-MEL-2 (human melanoma cells) and HaCaT (human keratinocyte cell line) |
Preparation Method | SK-MEL-2 and HaCaT cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37°C and 5% CO₂. Cells were treated with Protoporphyrin IX at concentrations of 10, 20, and 30mM for 48 hours. |
Reaction Conditions | 10, 20, and 30mM; 48h |
Applications | Protoporphyrin IX significantly increased melanogenesis, cellular tyrosinase activity, and the expression levels of tyrosinase, TRP-1, TRP-2, and MITF. PPIX also enhanced melanosome transport and dendricity in melanocytes by upregulating melanophilin, Rab27a, and Cdc42. These effects were mediated through the activation of the cGMP/PKG signaling pathway |
Animal experiment [2]: | |
Animal models | CF1 mice |
Preparation Method | Mice were intraperitoneally administered a single dose of Protoporphyrin IX (3.5mg/kg) or daily doses of Protoporphyrin IX (3.5mg/kg) for up to 5 doses. Mice were sacrificed at different time points after injection for liver and blood analysis. |
Dosage form | 3.5mg/kg; i.p. |
Applications | Protoporphyrin IX administration induced rapid liver damage, involving lipid peroxidation and alterations in antioxidant enzyme activities. A single dose of Protoporphyrin IX led to a transient increase in Cu-Zn superoxide dismutase (SOD) activity, while multiple doses resulted in sustained liver porphyrin accumulation and compromised antioxidant system, indicating severe liver damage. |
References: |
Cas No. | 553-12-8 | SDF | |
别名 | 原卟啉IX | ||
化学名 | 3-[18-(2-carboxyethyl)-8,13-bis(ethenyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid | ||
Canonical SMILES | O=C(CCC1=C2/C=C3C(CCC(O)=O)=C(C(/C=C(C(C)=C/4C=C)\NC4=C/C5=N/C(C(C=C)=C5C)=C\C(N2)=C1C)=N/3)C)O | ||
分子式 | C34H34N4O4 | 分子量 | 562.66 |
溶解度 | DMSO : 100mg/mL | 储存条件 | Store at 2-8°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
![]() |
1 mg | 5 mg | 10 mg |
1 mM | 1.7773 mL | 8.8864 mL | 17.7727 mL |
5 mM | 0.3555 mL | 1.7773 mL | 3.5545 mL |
10 mM | 0.1777 mL | 0.8886 mL | 1.7773 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet